Monday, September 16, 2024
- Advertisement -spot_img

TAG

commercialization

TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®, Approved in the European Union

Cambridge, Mass., June 24, 2024 (GLOBE NEWSWIRE) --  Biogen Inc. (Nasdaq: BIIB) announced that the European Commission (EC) has granted approval for TOFIDENCETM, a...

Latest news

- Advertisement -spot_img